Statistics review 11: Assessing risk

Relative risk and odds ratio have been introduced in earlier reviews (see Statistics reviews 3, 6 and 8). This review describes the calculation and interpretation of their confidence intervals. The different circumstances in which the use of either the relative risk or odds ratio is appropriate and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bewick, Viv, Cheek, Liz, Ball, Jonathan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522855/
https://www.ncbi.nlm.nih.gov/pubmed/15312212
http://dx.doi.org/10.1186/cc2908
_version_ 1782121862726156288
author Bewick, Viv
Cheek, Liz
Ball, Jonathan
author_facet Bewick, Viv
Cheek, Liz
Ball, Jonathan
author_sort Bewick, Viv
collection PubMed
description Relative risk and odds ratio have been introduced in earlier reviews (see Statistics reviews 3, 6 and 8). This review describes the calculation and interpretation of their confidence intervals. The different circumstances in which the use of either the relative risk or odds ratio is appropriate and their relative merits are discussed. A method of measuring the impact of exposure to a risk factor is introduced. Measures of the success of a treatment using data from clinical trials are also considered.
format Text
id pubmed-522855
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5228552004-10-17 Statistics review 11: Assessing risk Bewick, Viv Cheek, Liz Ball, Jonathan Crit Care Review Relative risk and odds ratio have been introduced in earlier reviews (see Statistics reviews 3, 6 and 8). This review describes the calculation and interpretation of their confidence intervals. The different circumstances in which the use of either the relative risk or odds ratio is appropriate and their relative merits are discussed. A method of measuring the impact of exposure to a risk factor is introduced. Measures of the success of a treatment using data from clinical trials are also considered. BioMed Central 2004 2004-06-30 /pmc/articles/PMC522855/ /pubmed/15312212 http://dx.doi.org/10.1186/cc2908 Text en Copyright © 2004 BioMed Central Ltd
spellingShingle Review
Bewick, Viv
Cheek, Liz
Ball, Jonathan
Statistics review 11: Assessing risk
title Statistics review 11: Assessing risk
title_full Statistics review 11: Assessing risk
title_fullStr Statistics review 11: Assessing risk
title_full_unstemmed Statistics review 11: Assessing risk
title_short Statistics review 11: Assessing risk
title_sort statistics review 11: assessing risk
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522855/
https://www.ncbi.nlm.nih.gov/pubmed/15312212
http://dx.doi.org/10.1186/cc2908
work_keys_str_mv AT bewickviv statisticsreview11assessingrisk
AT cheekliz statisticsreview11assessingrisk
AT balljonathan statisticsreview11assessingrisk

Ejemplares similares